LBA57 - Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3)
| Autor: | Felip, E., Nishio, M., Orlov, S., Park, K., Yu, C.-J., Tsai, C.-M., Cobo, M., McKeage, M., Su, W.-C., SK Mok, T., Scagliotti, G.V., Spigel, D., Passos, V.Q., Chen, Z., Shaw, A.T. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|